According to a recent market study published by Growth Market Reports, titled, “Global Topical Antivirals Market by type, herpes type, end-user, distribution channel, and region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 788.0 Million in 2022 and is anticipated to expand at a growth rate of 2.9% by 2031.

Get Sample Report @ https://growthmarketreports.com/request-sample/6103

Topical antivirals refer to medications that are applied directly to the skin to treat viral infections. These medications work by preventing the virus from replicating, thus controlling and eliminating the infection. Topical antivirals are commonly used to treat infections, such as herpes simplex virus, human papillomavirus, and some types of skin warts.

They are available in different forms, including creams, ointments, gels, and patches, and usually require a prescription from a healthcare provider. 
The global topical antivirals market has been segmented in terms of type, herpes type, end-user, distribution channel, and region. In terms of type, the global topical antivirals market is divided into branded and generics.

Based on herpes type, the market is segmented into herpes labialis and herpes genitalis. On the basis of end-user, the market is fragmented into hospitals, homecare, and clinics. In terms of distribution channel, the global topical antivirals market is divided into hospital pharmacies and retail pharmacies. In terms of regions, the market is separated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.


The Coronavirus disease 2019 (COVID-19) pandemic highlighted monetary differences, global interdependence, and governance challenges. However, the association of herpes simplex virus with the SARS-CoV-2 virus was established in many studies by researchers during the later phases of the pandemic.

For instance, according to a research study published in the Irish Journal of Medical Science in July 2021, herpes simplex virus type-1 and varicella-zoster viruses are strongly associated with COVID-19 infection, and the prevalence of the herpes simplex virus type-1 in the studied COVID-19 group was 2.81% as compared to 0.77% in the hospital population.

Moreover, it is evident that the pharmaceutical industry, including the production and distribution of topical antivirals, was affected by the COVID-19 pandemic. Several challenges were involved in the supply chain, such as disruptions in the manufacture of certain raw materials, transportation delays, reduced production capacities, and increased demand for certain medications. These factors affected the availability and pricing of topical antivirals in certain regions; however, the extent of the impact remains uncertain.


As per Growth Market Reports Senior Associate, Pratik Pandit, “The increasing incidence of viral infections, such as herpes simplex virus and human papillomavirus, is driving the topical antivirals market. Moreover, the rising awareness of personal hygiene and disease prevention is increasing the demand for topical antivirals among the general population. Technological advancements in drug formulations are expected to fuel the market.”

Key Takeaways from the Study:

  • Players in the global topical antivirals market include Amneal Pharmaceuticals LLC, Bausch Health Companies Inc, Cipla, FDC, GSK, Merit Pharmaceutical, Opsonin Pharma, Teva Pharmaceuticals USA, Inc, Zeelab Pharmacy, Zydus Group, and others. These companies held a key share of the global topical antivirals market in 2022.

  • The global topical antivirals market is primarily driven by factors such as increasing prevalence of viral infections. Rising incidence of viral infections, such as herpes, varicella-zoster virus, and human papillomavirus, is driving the demand for topical antivirals. Topical antivirals offer targeted therapy to treat localized viral infections, which is boosting its demand.

  • Furthermore, the global topical antivirals market is primarily driven by factors such as growing awareness of personal hygiene. Consumers are opting for topical antiviral products for the prevention of infectious diseases. Additionally, the growing awareness about the benefits of topical antivirals and improvements & technological advancements in drug formulations are driving the market.

  • Based on herpes type, the market is segmented into herpes labialis and herpes genitalis. The herpes genitalis segment held the largest market share in 2022 and is projected to expand at a CAGR of 3.0% over the forecast period, due to the increasing number of sexually transmitted infections caused by the herpes simplex virus (HSV).

  • In terms of region, the global topical antivirals market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America held 32.0% market share in 2022, owing to the established healthcare infrastructure in the region. Ongoing investments in research and development activities are resulting in the development of effective topical antivirals, thereby increasing the awareness of personal hygiene and prevention of infectious diseases. Consumers are opting for topical antiviral products, which is anticipated to boost the market in the coming years.

Topical Antivirals Market Report Scope:

Report Metric

Details

Market Value in 2022

US$ 788.0 Million

Market Growth Rate (from 2023 to 2031)

2.9%

Historical Data

2016 & 2021

Base Year

2022

Forecast Period

2023 – 2031

Units Considered

Value (US$ Million)

Market Segments

By Type, By Herpes Type, By End-user, By Distribution Channel, and By Region

Key Companies Profiled

Amneal Pharmaceuticals LLC, Bausch Health Companies Inc, Cipla, FDC, GSK, Merit Pharmaceutical, Opsonin Pharma, Teva Pharmaceuticals USA, Inc, Zeelab Pharmacy, Zydus Group, and Others.

Customization Scope

Report customization available on request.

Pricing and Purchase Options

Avail of tailor-made purchase options to meet your research requirements.

Target Audience:

  • Supply-side: Vendor, Manufacturer, Distributor, and Supplier.

  • Demand Side: Healthcare, Pharmaceuticals, and others.

  • Regulatory Side: Concerned government authorities and other approved regulatory bodies.

  • Associations and Industry Bodies: World Health Organization (WHO), Food Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), and National Health Expenditure (NIH).